A survey of oesophageal cancer: pathology, stage and clinical presentation

Background  Oesophageal adenocarcinoma is the sixth leading cause of cancer‐related mortality worldwide. Previously, oesophageal cancer was mainly squamous cell, presenting late with dysphagia and weight loss.

[1]  P. Dítě,et al.  [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.

[2]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[3]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[4]  C. Lightdale,et al.  Prognosis of esophageal cancers preoperatively staged to be locally invasive (T4) by endoscopic ultrasound (EUS): a multicenter retrospective cohort study. , 1995, Gastrointestinal endoscopy.

[5]  V. Gebski,et al.  A randomized phase III trial of preoperative chemoradiation followed by surgery (CR-S) versus surgery alone (S) for localized resectable cancer of the esophagus , 2002 .

[6]  A. Neugut,et al.  Epidemiology of upper gastrointestinal malignancies. , 2004, Seminars in oncology.

[7]  Navtej S Buttar,et al.  American Gastroenterological Association technical review on the role of the gastroenterologist in the management of esophageal carcinoma. , 2005, Gastroenterology.

[8]  S. Spechler,et al.  Clinical practice. Barrett's Esophagus. , 2002, The New England journal of medicine.

[9]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[10]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[11]  J. van Dam.  Endosonographic evaluation of the patient with esophageal cancer. , 1997, Chest.

[12]  D. Mathisen,et al.  Endoscopic ultrasound staging criteria for esophageal cancer. , 1997, Gastrointestinal endoscopy.

[13]  Endoscopy of the upper gastrointestinal tract. , 1975, Advances in surgery.

[14]  A. Stewart,et al.  Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. , 2000, Journal of the American College of Surgeons.

[15]  U. G. Dailey.  Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[16]  H. Stein,et al.  Staging and treatment of advanced esophageal cancer , 2005, Current opinion in gastroenterology.

[17]  J. Ferlay,et al.  Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18–29 (1999). , 1999, International journal of cancer.

[18]  M. Wiersema,et al.  A cost analysis of endoscopic ultrasound in the evaluation of esophageal cancer , 2002, American Journal of Gastroenterology.

[19]  H. Minn,et al.  Adenocarcinoma of the Esophagus and the Esophagogastric Junction: Positron Emission Tomography Improves Staging and Prediction of Survival in Distant but Not in Locoregional Disease , 2004, Journal of Gastrointestinal Surgery.

[20]  D. Forman.  Review article: oesophago‐gastric adenocarcinoma — an epidemiological perspective , 2004, Alimentary pharmacology & therapeutics.

[21]  C. Balch,et al.  AJCC Cancer Staging Manual. 6th ed , 2002 .

[22]  D. Ransohoff,et al.  Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. , 2002, JAMA.

[23]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[24]  J. Ferlay,et al.  Estimates of the worldwide mortality from 25 cancers in 1990 , 1999, International journal of cancer.

[25]  J. Lagergren.  Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk? , 2005, Gut.

[26]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[27]  D. Girling.  Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial , 2002, The Lancet.